Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Health Communication|October 27, 2020
Applying Best Practices from Health Communication to Support a University's Response to COVID-19M Mackert, B Table, J Yang, et al.
Clinical Immunology and Immunopathology|October 3, 1998
RANTES expression and contribution to monocyte chemotaxis in arthritisM V Volin, M R Shah, M Tokuhira, et al.
The American Journal of Pathology|October 5, 2001
Fractalkine: a novel angiogenic chemokine in rheumatoid arthritisM V Volin, J M Woods, M A Amin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2000
Reduction of inflammatory cytokines and prostaglandin E2 by IL-13 gene therapy in rheumatoid arthritis synoviumJ M Woods, K J Katschke, M Tokuhira, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|August 4, 1999
Interleukin-4 adenoviral gene therapy reduces production of inflammatory cytokines and prostaglandin E2 by rheumatoid arthritis synovium ex vivoJ M Woods, M Tokuhira, J C Berry, et al.
Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc|February 13, 2026
Detection of highly pathogenic avian influenza A(H5N1) clade 2.3.4.4b virus in cull dairy cows with underlying respiratory and systemic diseaseDaniel J Righter, Erin B Howey, Chris L Siepker, et al.
Experimental and Molecular Pathology|September 16, 1999
PECAM-1 and leukosialin (CD43) expression correlate with heightened inflammation in rat adjuvant-induced arthritisM V Volin, Z Szekanecz, M M Halloran, et al.
Arthritis and Rheumatism|June 17, 2000
Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritisZ Szekanecz, M M Halloran, M V Volin, et al.
Pageof 5